JUBLPHARMA

Jubilant Pharmova Limited

Pharmaceuticals

An integrated global pharmaceuticals company, Jubilant Pharmova operates across three core business segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. The company serves domestic and international markets through its diversified portfolio and specialized capabilities in drug development and manufacturing. It combines vertically integrated operations with expertise in custom synthesis and advanced pharmaceutical formulations to address healthcare needs across multiple therapeutic areas.

Investors holding Jubilant Pharmova Limited

Rekha Jhunjhunwala

Investor

3.28%

Government Pension Fund Global (Norway)

Foreign Investor

3.17%

EB

East Bridge Capital

Foreign Investor

2.53%

Quant Mutual Fund

Mutual Fund

1.85%

TI

Theleme India

Foreign Investor

1.69%

Abakkus Mutual Fund

Mutual Fund

1.15%

SBI Life Insurance

Institution

1.11%